Key clinical point: Molecular characterization of pediatric neuronal/glioneuronal tumors has improved in recent years.
Major finding: Molecular characterization provides additional diagnostic and treatment targets.
Study details: Review of multiple studies informing updated World Health Organization classifications.
Disclosures: Dr. Jones has no relevant financial relationships to disclose.
Jones DTW et al. CNS-ICNA 2020, Symposium: Neuro-oncology.